4.5 Article

Rationale for treatment and therapeutic options in Cushing's disease

Journal

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/S1521-690X(09)70004-1

Keywords

Cushing's syndrome; Cushing's disease; adrenocorticotrophic hormone (ACTH); pituitary

Funding

  1. NEON
  2. Novartis Pharma
  3. National Institute for Health Research [NF-SI-0508-10356] Funding Source: researchfish

Ask authors/readers for more resources

Cushing's disease results from prolonged overexposure of tissues to endogenous glucocorticoids, secondary to adrenocorticotrophin excess from the pituitary. Common clinical signs and symptoms include weight gain, hypertension, and osteoporosis. Effective treatment of Cushing's disease can normalize biochemical levels, reverse comorbidities, and improve overall survival and quality of life. Treatment options include pituitary or adrenal surgery, radiotherapy, and various medical therapies, but each has important limitations. Medical therapies that effectively target the pituitary tumour are urgently needed. (C) 2009 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available